TC
PLRX icon

Torno Capital’s Pliant Therapeutics PLRX Stock Holding History

Torno Capital’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$441K Buy
350,000
+30,000
+9% +$37.9K 0.06% 38
2025
Q4 		$390K Buy
320,000
+189,084
+144% +$284K 0.09% 56
2025
Q3 		$194K Buy
+130,916
New +$200K 0.02% 66

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Torno Capital's PLRX Position: Q1 2026 in Review

Torno Capital increased its Pliant Therapeutics (PLRX) stake by 9.4% in Q1 2026, buying an estimated $37.9K and bringing the position to 350,000 shares worth $441K. The position accounts for 0.06% of the portfolio, ranked #38.

Torno Capital first reported a position in PLRX in Q3 2025 and has held it in 3 quarters since. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Torno Capital held 350,000 shares of Pliant Therapeutics worth $441K as of Q1 2026.
  • Torno Capital bought 30,000 Pliant Therapeutics shares in Q1 2026, an estimated $37.9K.
  • Pliant Therapeutics made up 0.06% of Torno Capital's portfolio in Q1 2026, its #38 holding.
  • Torno Capital first reported a position in Pliant Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Torno Capital's 13F filing for Q1 2026, filed 15 May 2026.